Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
4,803 total articles
Walmart is a defensive giant with pricing power and operational scale, but a bumpy tariff backdrop and elevated valuation justify a measured, swing-oriented long. This trade targets a disciplined pullback entry, a reasonable upside to recent highs, and a stop that respects near-term volatility.
Equinor is trading near a 52-week high on positive headlines — buybacks and fresh Norwegian licenses — but momentum has room to run. Market-cap ~$81.98B, P/E ~16, and a 3.49% yield support a mid-term long. Trade plan provided for a mid-term (45 trading days) swing with defined risk controls.
Barclays (BCS) looks attractively priced after the market cooled off. The shares trade at about $23.36 with a market cap near $80.6B, a P/B around 0.91 and P/E roughly 10. With technical indicators showing oversold momentum and a wide 52-week range, this trade targets a re-rating toward the prior highs while keeping a tight stop to manage macro and…
Amylyx (AMLX) presents a high-risk, high-reward trade: the stock is trading at $15.05 with roughly $8.73 in cash per share and a $1.65B market cap. Positive LUCIDITY data expected by Q3 could materially re-rate shares; downside is meaningful if the readout disappoints or commercialization progress for other programs stalls. Our trade plan targets $…
Western Digital sits at the intersection of hyperscale storage demand and legacy HDD scale economics. With multi-year cloud contracts, improving margins and a market cap near $88.5B, WDC is a plausible play on continued AI data-center spending. This trade idea lays out an actionable long with a clear entry, stop and target, plus the catalysts and r…
StoneCo's shares trade at $14.29 with a sub-9x P/E and a $3.88B market cap after a volatile week. I am adding to my position because a modest repurchase program would translate into a double-digit buyback yield at today's valuation — and the company’s recent operating beats support that play.
Western Digital (WDC) looks like a compelling buy on the pullback caused by Sandisk-related share sales. Strong free cash flow, fat returns on equity, and multi-year data-center demand for high-capacity storage give WDC a credible path higher. I’m upgrading the trade rating to long with an entry at $263.50, stop at $210.00 and a target of $380.00 o…
StandardAero’s core maintenance, repair and overhaul (MRO) franchise sits at the intersection of secular aftermarket growth and near-term defense spending tailwinds. With durable revenue streams, improving margin levers and several near-term catalysts, the stock presents a favorable risk/reward for a long trade. Entry, stop and target are provided …
Moderna cleared a major legal overhang with a $950M settlement and has an FDA PDUFA goal date of 08/05/2026 on its seasonal flu application. With a market cap near $23.4B, negative free cash flow narrowing, and strong technical momentum, we initiate a buy with a mid-term horizon and defined risk controls.
DexCom looks set to benefit from an underappreciated demand tailwind as CGMs (continuous glucose monitors) are being prescribed alongside GLP-1 therapies. The stock is trading around $73, offers solid free cash flow and high ROE, and technicals show constructive momentum. This trade lays out a precise entry, stop and target for a long position over…
Simmons First (SFNC) is showing the hallmarks of a genuine turnaround: strong free cash flow, a rising dividend and a valuation below tangible book. The bank remains unprofitable on the headline EPS line, but low leverage, an attractive yield and a compact market cap create an asymmetric risk-reward for long-term value hunters. This is an upgrade t…
Turtle Beach has the product portfolio, retail relationships, and gaming-audio heritage that make it a logical beneficiary if Nintendo’s Switch 2 generates strong accessory demand. This trade idea lays out a long setup with entry, targets, stop, catalysts and risks tied to the hardware cycle.
RTX (RTX) is trading near multi-month highs as geopolitical risk and steady commercial programs drive demand. The company generates strong free cash flow and carries a defensible franchise across engines, avionics, sensors and missiles. We lay out an actionable long trade with entry, stop and target, plus catalysts and what would change our view.
Advanced Micro Devices is positioned to capture meaningful share and revenue upside from AI servers, PC Copilot+ chips, and large cloud deals. Valuation is rich versus history but justified by accelerating free cash flow, low leverage, and high-quality product momentum. We upgrade to a bullish trade with a clear entry, stop and target for a 180-tra…
Strathcona Resources (STHRF) trades at a low P/E and near-book valuation while showing bullish technicals and a 3.6% yield. We like a long position sized for conviction over a long-term trading horizon as the company scales thermal and EOR production and market sentiment normalizes.
International Seaways (INSW) sits near its 52-week high after a dramatic recovery from last year's lows. The company combines steady cash generation, a manageable debt load and an active capital-return policy. That mix supports a directional long with disciplined risk controls: enter near current levels, use a hard stop under the mid-$60s, and targ…
Expeditors (EXPD) looks like a classic cash-flow compounder that has been punished for a cyclical hit in ocean freight. With a market cap near $19.6B, roughly zero financial leverage, and $923M in free cash flow, the risk-reward supports a tactical long at current levels. This trade targets a recovery toward the 52-week high as AI and operational i…
Palantir is benefitting from renewed defense spending and a wave of commercial AIP adoption. Recent Q4 results, large government contracts, and elevated market attention create a window for a mid-term long trade. Valuation is rich, so risk-management and a clear stop are essential.
Iovance ($IOVA) is a commercially approved TIL (tumor-infiltrating lymphocyte) company whose lifileucel (Amtagvi) is generating real-world response rates above trial expectations. The stock is technically extended and has material short interest, so expect pullbacks. For disciplined traders, a controlled long entry around $4.12 with a $3.30 stop an…
Black Rock Coffee Bar (BRCB) is expanding rapidly with 170+ drive-thru locations and a stated ambition to reach 1,000 stores by 2035. The stock is trading near $15.88 with a market cap of roughly $795M. Technicals show short-term momentum while short interest and elevated valuation metrics leave room for volatility. This trade targets a mid-term up…
Navios Maritime Partners (NMM) has more than doubled from its 52-week low and is trading near its 52-week high. The business combines long-term contracted revenue and improving cash flow with a cheap P/E of 7.4 and PB of 0.65. For disciplined traders, there's a favorable risk-reward: enter on strength or small pullback, target $90, stop $62, with a…
APA has reshaped its cost base and balance sheet while retaining a steady dividend. With oil prices buoyed by ongoing Middle East tensions, APA’s cheap valuation (EV/EBITDA ~3.0, P/E ~8) and strong free cash flow ($1.805B) support a tactical long trade. Entry $30.75, stop $28.00, target $36.00 over a mid-term (45 trading days) horizon.
Caterpillar sits at the intersection of AI data-center buildouts, mining-driven commodity demand, and the transition to electrified, autonomous equipment. The stock looks expensive on headline multiples, but strong cash flow, a fortress-like balance sheet and a real, underappreciated bottleneck in heavy-site construction make a disciplined long tra…
Progyny (PGNY) is a leading fertility benefits manager that has seen its share price compress amid transitional headwinds and scrutiny. With $191.8M in trailing free cash flow, a market cap near $1.46B and conservative balance-sheet metrics, the risk-reward favors a tactical long in the mid-term (45 trading days). This trade targets a return to the…
Moderna's $950 million settlement removes a major legal overhang and preserves cash runway assumptions, letting management refocus on respiratory franchises and oncology/rare-disease programs. The stock is trading near a 52-week high on bullish technicals and improving regulatory news; we favor a mid-term long with defined risk management.
